Pilgrim Partners Asia Pte Ltd Takes Position in The Beauty Health Company (NASDAQ:SKIN)

Pilgrim Partners Asia Pte Ltd acquired a new position in The Beauty Health Company (NASDAQ:SKIN) during the 4th quarter, Holdings Channel reports. The firm acquired 36,000 shares of the company’s stock, valued at approximately $57,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in SKIN. Sanctuary Advisors LLC boosted its stake in shares of Beauty Health by 49.2% during the 3rd quarter. Sanctuary Advisors LLC now owns 36,695 shares of the company’s stock worth $52,000 after acquiring an additional 12,103 shares during the last quarter. HighTower Advisors LLC bought a new stake in Beauty Health during the third quarter valued at about $121,000. FMR LLC increased its position in Beauty Health by 0.3% in the third quarter. FMR LLC now owns 18,603,037 shares of the company’s stock worth $26,788,000 after buying an additional 58,826 shares in the last quarter. SG Americas Securities LLC raised its stake in shares of Beauty Health by 38.2% in the fourth quarter. SG Americas Securities LLC now owns 35,290 shares of the company’s stock worth $56,000 after buying an additional 9,749 shares during the period. Finally, Barclays PLC lifted its position in shares of Beauty Health by 224.7% during the 3rd quarter. Barclays PLC now owns 106,103 shares of the company’s stock valued at $153,000 after buying an additional 73,425 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reduced their target price on shares of Beauty Health from $1.75 to $1.50 and set a “hold” rating for the company in a report on Thursday, March 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.50.

Beauty Health Stock Performance

NASDAQ SKIN opened at $1.20 on Friday. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23. The Beauty Health Company has a twelve month low of $0.91 and a twelve month high of $3.92. The business has a 50-day moving average price of $1.46 and a 200-day moving average price of $1.54. The firm has a market cap of $150.29 million, a price-to-earnings ratio of -2.86 and a beta of 0.84.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.02. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. The business had revenue of $83.50 million during the quarter, compared to analyst estimates of $78.02 million. During the same period last year, the firm posted ($0.07) EPS. As a group, equities research analysts predict that The Beauty Health Company will post -0.25 EPS for the current fiscal year.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.